- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07637565
Artificial Intelligence-based Dietary Care System (AI DC-system)
3 juni 2026 uppdaterad av: National Taiwan University Hospital
Effectiveness of An Artificial Intelligence-based Dietary Care System for Distress From Altered Bowel Function and Quality of Life in Rectal Cancer Patients With Low Anterior Resection Syndrome
Patients with rectal cancer complicated by low anterior resection syndrome who undergo anal-preserving surgery may experience severe distress in daily life due to changes in bowel function, thus requiring significant post-discharge care support from healthcare professionals.
This study is a multicenter, non-blinded randomized controlled trial.
One hundred patients with rectal cancer complicated by low anterior resection syndrome are planned to be randomly assigned in a 1:1 ratio from the colorectal surgery outpatient clinics of National Taiwan University Hospital, its Cancer Center, and its Yunlin Branch.
They will be divided into a control group receiving routine dietary education and an experimental group receiving both routine dietary education and the use of an artificial intelligence-based dietary care system application.
The artificial intelligence-based dietary care system application will be used for approximately six months.
Three questionnaires will be administered at one month post-surgery (before intervention), three months post-surgery, and six months post-surgery.
The questionnaires will include: a demographic data sheet, a low anterior resection syndrome score, distress inventory from altered bowel functioning, and the European Organization for Research and Treatment of Cancer QLQ-30 Scale, to verify the effectiveness of the artificial intelligence-based dietary care system application in improving bowel disturbance and quality of life in patients with rectal cancer complicated by low anterior resection syndrome.
Studieöversikt
Status
Har inte rekryterat ännu
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Beräknad)
100
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studiekontakt
- Namn: Ling-Chun Lu, PhD
- Telefonnummer: 886-2-33665589
- E-post: lulingchun@ntu.edu.tw
Studieorter
-
-
-
Taipei, Taiwan, 10617
- National Taiwn University, College of Medicine
-
Kontakt:
- Ling-Chun Lu, PhD
- Telefonnummer: 886-2-33665589
- E-post: lulingchun@ntu.edu.tw
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Nej
Beskrivning
Inclusion Criteria:
- Age ≥18 years.
- Clear consciousness with ability to communicate in Mandarin or Taiwanese.
- Histopathological confirmation of rectal adenocarcinoma.
- Undergoing radical rectal resection or such surgery combined with temporary stoma closure.
Exclusion Criteria:
- Diagnosis of other intestinal disorders, including intestinal tumors, bloating, obstruction, ulcerative colitis, or irritable bowel syndrome.
- Inability to access the internet.
- Inability to use a smartphone.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Artificial Intelligence-based Dietary Care System
Care program will conduct by Artificial Intelligence-based Dietary Care System.
|
|
|
Aktiv komparator: Routine care
Routine dietary education during hospitalization is provided via hospital-developed electronic materials accessible through QR code scanning.
|
Content covers postoperative dietary progression, nutritional supplementation, intake principles, and food avoidance.
The postoperative regimen typically advances through four stages-clear liquid, low-residue semi-liquid, low-residue soft, and regular diet-with most patients resuming normal intake within one month.
Guidance emphasizes high-protein, high-calorie foods, small frequent meals, and balanced nutrition, while advising avoidance of gas-producing, odorous, coarse-fiber, greasy, spicy, pickled, and dairy products.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
Tidsram: Three-time frames are at one-month post-surgery (before intervention), three- months post-surgery, and six-months post-surgery.
|
This 30-item instrument assesses cancer-related QoL across global health, five functional domains (physical, role, cognitive, emotional, and social), and nine symptom scales (fatigue, nausea/vomiting, pain, dyspnea, sleep disturbance, appetite loss, constipation, diarrhea, and financial difficulty) [22, 23].
Higher scores for functioning and global health indicate better QoL, whereas higher symptom scores denote greater symptom burden.
|
Three-time frames are at one-month post-surgery (before intervention), three- months post-surgery, and six-months post-surgery.
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Distress Inventory for Altered Bowel Functioning (DI-ABF)
Tidsram: Three-time frames are at one-month post-surgery (before intervention), three- months post-surgery, and six-months post-surgery.
|
Developed by Lu et al., the 16-item DI-ABF measures distress arising from altered bowel functioning across three domains: daily life, emotional regulation, and social functioning, with higher scores reflecting greater distress.
Cut point 9.5 divided to be no bowel-related distress (0-9.5) and bowel-related distress (>9.5).
|
Three-time frames are at one-month post-surgery (before intervention), three- months post-surgery, and six-months post-surgery.
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Low Anterior Resection Syndrome (LARS) Score
Tidsram: Three-time frames are at one-month post-surgery (before intervention), three- months post-surgery, and six-months post-surgery.
|
Developed by Emmertsen and Laurberg [21], this tool evaluates five aspects of bowel dysfunction: flatus incontinence, fecal incontinence, bowel frequency, clustering, and urgency.
Scores range from 0 to 42, with higher scores indicating more severe symptoms.
Severity is categorized as no LARS (0-20), minor LARS (21-29), and major LARS (30-42).
|
Three-time frames are at one-month post-surgery (before intervention), three- months post-surgery, and six-months post-surgery.
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Beräknad)
1 juli 2026
Primärt slutförande (Beräknad)
31 december 2027
Avslutad studie (Beräknad)
31 december 2028
Studieregistreringsdatum
Först inskickad
3 juni 2026
Först inskickad som uppfyllde QC-kriterierna
3 juni 2026
Första postat (Faktisk)
10 juni 2026
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
10 juni 2026
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
3 juni 2026
Senast verifierad
1 juni 2026
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 202603195RIND
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
IPD-planbeskrivning
For privacy protection considerations, no individual praticipant data will be shared.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .